The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia
The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia
To report the possible role of S.B 8.4% in the treatment of COVID-19pneumonia.
Inclusion Criteria:

 -  Age >18 years.

 -  Fever ≥ 38º C with upper respiratory tract manifestations, generalized bone ache with
 or without gastrointestinal symptoms as diarrhea.

 -  Chest CT with signs suggestive of COVID-19.

 -  Mild and moderate cases of COVID-19 pneumonia with respiratory and hemodynamic
 stability. - High C reactive protein (CRP).- With or without history of contact with
 index case who is isolated in a governmental hospital assigned for treatment of
 patients proved to have RT-PCR positive test for COVID-19

 -  With or without abnormalities in the total or differential white cell count.

 -  Welling to sign a fully informed consent.

 Exclusion Criteria:

 -  Severe and critical illness with respiratory failure and/ or hemodynamic instability.

 -  CT with pleural effusion with or without lung cavitation.

 -  Other organ failure.